Cargando…

Interferon-γ +874A/T Polymorphism and Hepatocellular Carcinoma Risk: A Meta-Analysis

BACKGROUND: Studies have evaluated the association between interferon-γ (IFN-γ) +874A/T polymorphism and hepatocellular carcinoma (HCC) risk, but the results are controversial. We performed this meta-analysis to further investigate this association. MATERIAL/METHODS: Relevant studies were searched b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huan, Wang, Lizhou, Li, Xing, Song, Jie, Jiang, Tianpeng, Wu, Xiaoping, Zhou, Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360746/ https://www.ncbi.nlm.nih.gov/pubmed/25739411 http://dx.doi.org/10.12659/MSM.892885

Ejemplares similares

Association between the interferon-γ +874T/A polymorphism and susceptibility to hepatitis B virus infection: a meta-analysis
por: Li, Liang
Publicado: (2020)

IFN-γ +874 A>T (rs2430561) gene polymorphism and risk of pulmonary tuberculosis: a meta-analysis
por: Areeshi, Mohammed Y., et al.
Publicado: (2019)

XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis
por: Zhou, Qiang, et al.
Publicado: (2021)

Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis
por: Kong, Cunqing, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis
por: Zhang, Qian, et al.
Publicado: (2020)

Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
por: Cao, Guangchao, et al.
Publicado: (2015)

Repeat resection versus percutaneous ablation for recurrent hepatocellular carcinoma: a meta-analysis
por: Zhang, Feng-Qin, et al.
Publicado: (2022)

Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis
por: Chang, Yue, et al.
Publicado: (2020)

Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis
por: Wei, Zhijiang, et al.
Publicado: (2015)

Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis
por: Song, De-Hua, et al.
Publicado: (2016)

Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles
por: Ding, Yan, et al.
Publicado: (2017)

Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis
por: Zhang, Yue, et al.
Publicado: (2017)

Hepatocellular carcinoma recurrence in living and deceased donor liver transplantation: a systematic review and meta-analysis
por: Zhang, Hai-Ming, et al.
Publicado: (2019)

Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis
por: Jiang, Ya-Lin, et al.
Publicado: (2019)

Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis
por: Wan, Tao, et al.
Publicado: (2017)

Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
por: Shang, Jin, et al.
Publicado: (2017)

Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis
por: Bhat, Venkat, et al.
Publicado: (2018)

Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis
por: Liang, Xianghua, et al.
Publicado: (2017)

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

The association between BRCA1 gene polymorphism and cancer risk: a meta-analysis
por: Xu, Gui-Ping, et al.
Publicado: (2018)

Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer
por: Xu, Bin, et al.
Publicado: (2018)

Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis
por: Cheng, Liqing, et al.
Publicado: (2015)

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
por: Fong, Khi Yung, et al.
Publicado: (2022)

lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis
por: Zheng, Chuqian, et al.
Publicado: (2017)

Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis
por: Hou, Qi, et al.
Publicado: (2017)

Meta-Analysis of Combination Therapy of Chinese Herbs Plus Interferon and Ribavirin in Patients with Chronic Hepatitis C
por: Wang, Jianjun, et al.
Publicado: (2016)

Interleukin-10-1082A/G Polymorphism and Diabetic Nephropathy: A Meta-Analysis
por: Peng, Xia, et al.
Publicado: (2015)

Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients’ data
por: Huan, Hong-Bo, et al.
Publicado: (2017)

Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis
por: Gu, Wang, et al.
Publicado: (2020)

Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Hu, et al.
Publicado: (2021)

Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis
por: Lee, Aaron JL, et al.
Publicado: (2023)

Comparative effectiveness of different hepatocellular carcinoma screening intervals or modalities: a systematic review and meta-analysis
por: Yang, Jichun, et al.
Publicado: (2023)

Association between interleukin-8 −251A/T polymorphism and the risk of tuberculosis: A meta-analysis
por: Hu, Qin, et al.
Publicado: (2020)

Meta-analysis of the association between three microRNA polymorphisms and breast cancer susceptibility
por: Mu, Kun, et al.
Publicado: (2017)

Association between MTHFR C677T Polymorphism and Risk of Acute Lymphoblastic Leukemia: A Meta-Analysis Based on 51 Case-Control Studies
por: Li, Su-yi, et al.
Publicado: (2015)

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study
por: Chen, Huaping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h34ou0sus2viv1vdu15puf5t6u